All News
Filter News
Found 808,906 articles
-
ESSC Receives $1.75 Million Donation From David and Molly Pyott Foundation to Transform Former Santa Ana Corporate Offices Into Adult Day Services Center; Groundbreaking June 22nd
6/22/2018
Corporate Offices to Relocate to Irvine June 25th
-
Beleave Applauds Canadian Leadership and Continued Progress of Cannabis Legalization
6/22/2018
As the first G7 country to legalize cannabis, this forever reaffirms Canada's reputation as a forward-thinking nation to live and do business in.
-
Rocket Pharmaceuticals to Join Russell 3000® and 2000® Indexes
6/22/2018
The newly reconstituted indexes take effect after the close on Friday, June 22, 2018.
-
A Wireless Medical Devices Manufacturer Developed a Demand and Supply Planning Framework with Supply Chain Analytics - Book a Solution Demo Now | Quantzig
6/22/2018
A popular company specializing in the manufacturing of wireless medical devices wanted to devise a demand and supply planning framework using a two-step approach.
-
Elizabeth O'Farrell Named to PDL BioPharma's Board of Directors
6/22/2018
Election effective June 22, 2018 and increasing the number of directors to nine.
-
William A. Haseltine, PhD Joins Grace Therapeutics' Board of Directors
6/22/2018
Pioneering Scientist and Former CEO of Human Genome Sciences Brings Key Expertise to Grace's Board
-
Replimune Appoints Dieter K. Weinand to Board of Directors
6/22/2018
Dieter brings a wealth of strategic and operational experience to Replimune that will strengthen the perspectives of the Board and guide the Company at this exciting time.
-
Wounded Warrior Project Veteran Hosts Public Yoga Event in Chicago on June 30
6/22/2018
Leading this relaxing and empowering event is Army veteran Dan Nevins, who will also share the story of his recovery and return to civilian life.
-
Righttime Medical Care and HeadFirst Concussion Care Welcome Chesapeake Neurology Associates
6/22/2018
Established in 1992, Chesapeake Neurology Associates see patients for a wide range of neurological and psychological evaluations and concerns including traumatic brain injury and concussion.
-
Canadian Cannabis Legalization Helps to Deter Illegal Markets
6/22/2018
The market is expected to be driven by the widespread legalization in several countries, due to the high demand for both medical and recreational uses.
-
The Future of Bioprinting is Here: Poietis and Prometheus Team Up To Develop 3D Printing for Bones
6/21/2018
Poietis along with Prometheus, a division of Skeletal Tissue Engineering at Leuven, Belgium, announced they had entered into a two-year Collaborative Research Agreement to develop high-precision 3D Bioprinting. -
BrainStorm Considers Offering Experimental NurOwn to ALS Patients Under Right-to-Try for a Hefty ...
6/21/2018
The first company has provided a potential out-of-pocket price for patients who seek access through the recently passed federal Right-to-Try legislation and it’s not cheap. -
Purdue Pharma, best known for selling painkiller OxyContin, announced it laid off approximately 350 staffers.
-
June is Alzheimer’s & Brain Awareness Month and June 21 is dubbed “The Longest Day,” which focuses on raising awareness of Alzheimer’s disease.
-
It’s a super-busy week for biotech initial public offerings (IPOs) with six companies raking in a total of around $568 million.
-
Former Puma Biotechnology Executive Sentenced to More than Two Years in Prison for Insider Trading
6/21/2018
Robert Gadimian, a former executive with Puma Biotechnology, was sentenced to more than two years in prison for insider trading. -
A new report highlights some concerns about the long-term commercial viability of game-changing gene therapies that can radically transform the lives of patients.
-
Novo Nordisk’s semaglutide, an oral GLP-1 analogue, continues to rack up positive Phase III clinical trial data compared to its competitors.
-
Shares of Incyte Corporation are up slightly this morning after the company started off its annual R&D day with positive news from its pivotal REACH1 study of Jakafi (ruxolitinib) in steroid-refractory acute graft-versus-host disease (GVHD) and sets up the filing of a supplemental New Drug Applic...
-
Oramed Initiates Food Effect Study for Its Oral Insulin Capsule ORMD-0801
6/21/2018
Up to 48 subjects will be enrolled including 24 healthy volunteers and 24 subjects with type 1 diabetes.